• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Herbalife Nutrition Ltd. (Amendment)

    8/8/22 4:16:08 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care
    Get the next $HLF alert in real time by email
    SC 13G/A 1 d321699dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 4)*

     

     

    Herbalife Nutrition Ltd.

    (Name of Issuer)

    Common Shares, par value $0.0005 per share

    (Title of Class of Securities)

    G4412G101

    (CUSIP Number)

    August 4, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐

    Rule 13d-1(b)

     

    ☒

    Rule 13d-1(c)

     

    ☐

    Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

     

     

     


    CUSIP No. G4412G101    13G    Page 2 of 5

     

      1.    

      NAMES OF REPORTING PERSONS

     

      HBL Swiss Services GmbH (formerly known as HBL Swiss Financing GmbH)

      2.  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☐

     

      3.  

      SEC USE ONLY

     

      4.  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Switzerland

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5.     

      SOLE VOTING POWER

     

      0

       6.   

      SHARED VOTING POWER

     

      0

       7.   

      SOLE DISPOSITIVE POWER

     

      0

       8.   

      SHARED DISPOSITIVE POWER

     

      0

      9.    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      0

    10.  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11.  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      0

    12.  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO


    CUSIP No. G4412G101    13G    Page 3 of 5

    Explanatory Note

    The 10,025,020 Common Shares (as defined below) previously owned by HBL Swiss Services GmbH (formerly known as HBL Swiss Financing GmbH), an indirect wholly-owned subsidiary of Herbalife Nutrition Ltd. (the “Issuer”), were repurchased by Issuer on August 4, 2022 through an intercompany transaction at a per share price equal to the closing price of the Common Shares on the New York Stock Exchange on the date of the transaction and have been cancelled. Such shares have been previously accounted for by Issuer as treasury shares under U.S. GAAP and therefore, even though such shares were outstanding, they were not included in the number of Common Shares outstanding within the Issuer’s condensed consolidated financial statements and the weighted-average number of Common Shares outstanding used in calculating earnings per share while such shares were held by HBL Swiss Services GmbH. As a result, this repurchase and the subsequent cancellation will not impact earnings per share calculation for the third quarter ending September 30, 2022 or the year-ending December 31, 2022.

     

    Item 1(a).

    Name of Issuer:

    Herbalife Nutrition Ltd. (the “Issuer”)

     

    Item 1(b).

    Address of Issuer’s Principal Executive Offices:

    P.O. Box 309, Ugland House, Grand Cayman, Cayman Islands

     

    Item 2(a).

    Name of Person Filing:

    HBL Swiss Services GmbH (formerly known as HBL Swiss Financing GmbH), an indirect wholly-owned subsidiary of the Issuer (“SwissCo”).

     

    Item 2(b).

    Address of Principal Business Office or, if None, Residence:

    Hansmatt 32, CH-6370 Stans NW, Switzerland

     

    Item 2(c).

    Citizenship:

    SwissCo is a Swiss company with limited liability.

     

    Item 2(d).

    Title of Class of Securities:

    Common shares of the Issuer, par value $0.0005 per share (“Common Shares”)

     

    Item 2(e).

    CUSIP Number:

    G4412G101

     

    Item 3.

    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

      (a)

    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

     

      (b)

    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

     

      (c)

    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

     

      (d)

    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

     

      (e)

    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

     

      (f)

    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).

     

      (g)

    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).

     

      (h)

    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).

     

      (i)

    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).

     

      (j)

    A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J).

     

      (k)

    Group, in accordance with §240.13d-1(b)(1)(ii)(K).

    Not applicable.


    CUSIP No. G4412G101    13G    Page 4 of 5

     

    Item 4.

    Ownership.

     

      (a)

    Amount beneficially owned:

    SwissCo is the beneficial owner of 0 Common Shares.

     

      (b)

    Percent of class:

    SwissCo is the beneficial owner of 0% of the outstanding Common Shares.

     

      (c)

    Number of shares as to which the person has:

     

      (i)

    Sole power to vote or to direct the vote:

    SwissCo has the sole power to vote or to direct the vote over 0 Common Shares.

     

      (ii)

    Shared power to vote or to direct the vote:

    SwissCo has the shared power to vote or to direct the vote over 0 Common Shares.

     

      (iii)

    Sole power to dispose or to direct the disposition of:

    SwissCo has the sole power to dispose or to direct the disposition of 0 Common Shares.

     

      (iv)

    Shared power to dispose or to direct the disposition of:

    SwissCo has the shared power to dispose or to direct the disposition of 0 Common Shares.

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following:  ☒

     

    Item 6.

    Ownership of More Than Five Percent on Behalf of Another Person.

    Not applicable.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    Not applicable.

     

    Item 8.

    Identification and Classification of Members of the Group.

    Not applicable.

     

    Item 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    Item 10.

    Certifications.

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.


    CUSIP No. G4412G101    13G    Page 5 of 5

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: August 8, 2022

     

    HBL Swiss Services GmbH
    By:  

    /s/ Richard Caloca

    Name:   Richard Caloca
    Title:   Manager
    Get the next $HLF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLF

    DatePrice TargetRatingAnalyst
    1/6/2026$20.00Buy
    Maxim Group
    11/26/2025Hold → Buy
    Argus
    3/21/2025$7.50 → $14.00Neutral → Buy
    DA Davidson
    8/1/2024$16.00 → $17.00Buy
    B. Riley Securities
    9/14/2023$13.50Neutral
    DA Davidson
    6/7/2023$13.00Neutral
    Mizuho
    2/3/2023$14.00Underperform
    BofA Securities
    7/12/2022$26.00Hold → Buy
    Jefferies
    More analyst ratings

    $HLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Herbalife Ltd.

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    12/1/25 9:00:53 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Cloud Lynda bought $152,490 worth of shares (17,000 units at $8.97), increasing direct ownership by 78% to 38,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/20/25 8:41:01 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form 4 filed by Chief Commercial Officer Lamberti Frank

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/18/25 6:37:50 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Herbalife to Announce Fourth Quarter and Full-Year 2025 Results on February 18

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its fourth quarter and full-year 2025 financial results after the close of trading on the NYSE on Wednesday, February 18, 2026. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/si6puiij Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server

    1/5/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife CFO Fireside Chat Webcast from Furey Research Partners Hidden Gems Conference Available

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced John DeSimone, Chief Financial Officer, participated in a fireside chat at the Furey Research Partners Hidden Gems Conference on Monday, November 24. The webcast is now available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/ and will remain accessible for six months. For more information about Furey Research Partners, please visit https://www.fureyresearch.com/. About Herbalife Ltd. Herbalife (NYSE:HLF) is a premier health and wellness company, community and platform that has been changing people's lives with great nutrition products and a

    11/25/25 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife CEO and CFO to Participate in BofA Securities Leveraged Finance Conference on December 2

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced Stephan Gratziani, Chief Executive Officer and John DeSimone, Chief Financial Officer, will participate in a fireside chat at the BofA Securities Leveraged Finance Conference on Tuesday, December 2, 2025 at 8:10 a.m. ET (5:10 a.m. PT). A link to the live webcast will be available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/. A replay of the webcast will also be available at the same website following the completion of the event and for six months thereafter. About Herbalife Ltd. Herbalife (NYSE:HLF) is a premier health and wellness compa

    11/19/25 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cloud Lynda bought $152,490 worth of shares (17,000 units at $8.97), increasing direct ownership by 78% to 38,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/20/25 8:41:01 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    6/9/25 6:00:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/23/25 4:01:25 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Herbalife Ltd.

    SCHEDULE 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    2/12/26 2:14:18 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - HERBALIFE LTD. (0001180262) (Filer)

    11/5/25 4:27:57 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form 10-Q filed by Herbalife Ltd.

    10-Q - HERBALIFE LTD. (0001180262) (Filer)

    11/5/25 4:18:28 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on Herbalife Nutrition with a new price target

    Maxim Group initiated coverage of Herbalife Nutrition with a rating of Buy and set a new price target of $20.00

    1/6/26 9:08:50 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition upgraded by Argus

    Argus upgraded Herbalife Nutrition from Hold to Buy

    11/26/25 7:50:23 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition upgraded by DA Davidson with a new price target

    DA Davidson upgraded Herbalife Nutrition from Neutral to Buy and set a new price target of $14.00 from $7.50 previously

    3/21/25 8:38:07 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/14/24 4:11:11 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G filed by Herbalife Ltd.

    SC 13G - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 4:01:31 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 12:49:27 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Leadership Updates

    Live Leadership Updates

    View All

    Herbalife Welcomes Lynda Cloud to its Board of Directors

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife's continued commitment to innovation, digital transformation, and personalized wellness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425107883/en/Herbalife Welcomes Lynda Cloud to the Board of Directors Lynda Cloud's decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife's next chapter. Her deep expertise in digital learning, consumer experie

    4/25/25 5:12:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Appoints Stephan Gratziani as Chief Executive Officer

    Current CEO Michael Johnson Transitions to Executive Chairman Herbalife Ltd. (NYSE:HLF) today announced its Board of Directors has appointed President, Stephan Gratziani as Chief Executive Officer (CEO) effective May 1, 2025. Michael Johnson, current CEO and Chairman of the Board, will transition to Executive Chairman. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219653469/en/Herbalife appoints Stephan Gratziani as Chief Executive Officer (Photo: Business Wire) As a former Herbalife independent distributor, Mr. Gratziani built and grew his international business into one of the top global distributorships. For 32 years, he

    2/19/25 4:05:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Expands Board of Directors with Appointment of Perkins Miller

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today welcomed experienced e-commerce and media technology executive Perkins Miller to its board of directors. Miller's appointment as an independent director is effective June 26, 2024. "Perkins brings valuable, proven expertise in leading large-scale e-commerce, technology and sports enterprises, which will be a great asset to our Board as the Company continues to grow and transform," said Michael Johnson, Chairman and CEO of Herbalife. Miller is the CEO of Fandom, the world's largest fan platform where fans immerse themselves in imagined worlds across entertainment and gaming, where he has trans

    6/26/24 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Financials

    Live finance-specific insights

    View All

    Herbalife to Announce Fourth Quarter and Full-Year 2025 Results on February 18

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its fourth quarter and full-year 2025 financial results after the close of trading on the NYSE on Wednesday, February 18, 2026. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/si6puiij Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server

    1/5/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife to Announce Third Quarter 2025 Results on November 5

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its third quarter 2025 financial results after the close of trading on the NYSE on Wednesday, November 5, 2025. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/4btutrtf Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BI

    10/1/25 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Reports Q2 Net Sales Near Guidance Midpoint; Q2 Adjusted EBITDA1 Exceeds Guidance; Raises Net Sales and Adjusted EBITDA1 Full-Year Guidance

    Highlights MultiBurn™ Launch and Unveiling of Beta Version of Pro2col App and Healthy Lifespan Supplement Herbalife Ltd. (NYSE:HLF) today reported financial results for the second quarter ended June 30, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806517228/en/ "Herbalife is entering a pivotal new era. The beta release of our AI-assisted Pro2col™ app at our North America Extravaganza, with over 7,000 distributors joining this early access phase, marks a bold and powerful first step." - Stephan Gratziani, CEO Highlights Second Quarter 2025 Net sales of $1.3 billion near midpoint of guidance range Down 1.7% vs.

    8/6/25 4:10:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care